Mattoo, R (2021) Targeting emerging Mycobacterium avium infections: Perspectives into pathways and antimicrobials for future interventions. In: Future Microbiology, 16 (10). pp. 753-764.
Full text not available from this repository.Abstract
Mycobacterium avium is an emerging opportunistic pathogen, globally. Infections caused by M. avium are laborious to treat and could result in drug resistance. This review discusses the importance of many factors including the cell wall in M. avium pathogenesis, since this unique structure modulates the pathogen's ability to thrive in various hosts and environmental niches including conferring resistance to killing by antimicrobials. More research efforts in future are solicited to develop novel therapeutics targeting M. avium. The complete eradication of M. avium infection in immunocompromised individuals would need a deeper understanding of the source of infection, unique underlying mechanisms and its uncharacterized pathways. This could, perhaps in future, hold the key to target and treat M. avium more effectively. © 2021 Future Medicine Ltd.
| Item Type: | Journal Article |
|---|---|
| Publication: | Future Microbiology |
| Publisher: | Future Medicine Ltd. |
| Additional Information: | The copyright for this article belongs to Future Medicine Ltd. |
| Department/Centre: | Division of Mechanical Sciences > Divecha Centre for Climate Change |
| Date Deposited: | 16 Nov 2021 10:17 |
| Last Modified: | 16 Nov 2021 10:23 |
| URI: | http://eprints.iisc.ac.in/id/eprint/69668 |
Actions (login required)
 |
View Item |
